Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Clin Gastroenterol Hepatol

Retrieve available abstracts of 259 articles:
HTML format



Single Articles


    July 2022
  1. JENA A, James D, Singh AK, Dutta U, et al
    Effectiveness and Durability of COVID-19 Vaccination in 9447 Patients With IBD: A Systematic Review and Meta-Analysis.
    Clin Gastroenterol Hepatol. 2022;20:1456-1479.
    PubMed     Abstract available


  2. AKIYAMA S, Rodriguez TG, Rubin DT
    Stratifying Risks of Ileal Pouch Outcomes.
    Clin Gastroenterol Hepatol. 2022;20:1620-1621.
    PubMed    


  3. NARULA N, Wong ECL, Dulai PS, Sengupta NK, et al
    Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naive Crohn's Disease.
    Clin Gastroenterol Hepatol. 2022;20:1579-1587.
    PubMed     Abstract available


  4. BATTAT R, Sandborn WJ
    Advances in the Comprehensive Management of Postoperative Crohn's Disease.
    Clin Gastroenterol Hepatol. 2022;20:1436-1449.
    PubMed     Abstract available


    June 2022
  5. RIVIERE P, Bislenghi G, Vermeire S, Domenech E, et al
    Postoperative Crohn's Disease Recurrence: Time to Adapt Endoscopic Recurrence Scores to the Leading Surgical Techniques.
    Clin Gastroenterol Hepatol. 2022;20:1201-1204.
    PubMed    


  6. KOCHAR B, Pate V, Kappelman MD, Long MD, et al
    Vedolizumab Is Associated With a Lower Risk of Serious Infections Than Anti-Tumor Necrosis Factor Agents in Older Adults.
    Clin Gastroenterol Hepatol. 2022;20:1299-1305.
    PubMed     Abstract available


  7. LIU Q, Zhang X, Ko HM, Stocker D, et al
    Constrictive and Hypertrophic Strictures in Ileal Crohn's Disease.
    Clin Gastroenterol Hepatol. 2022;20:e1292-e1304.
    PubMed     Abstract available


  8. DE GREGORIO M, Lee T, Krishnaprasad K, Amos G, et al
    Higher Anti-tumor Necrosis Factor-alpha Levels Correlate With Improved Radiologic Outcomes in Crohn's Perianal Fistulas.
    Clin Gastroenterol Hepatol. 2022;20:1306-1314.
    PubMed     Abstract available


  9. FINK M, Simons M, Tomasino K, Pandit A, et al
    When Is Patient Behavior Indicative of Avoidant Restrictive Food Intake Disorder (ARFID) Vs Reasonable Response to Digestive Disease?
    Clin Gastroenterol Hepatol. 2022;20:1241-1250.
    PubMed     Abstract available


    May 2022
  10. STRAATMIJER T, Biemans VB, Visschedijk M, Hoentjen F, et al
    Superior effectiveness of tofacitinib compared to vedolizumab in anti-TNF experienced ulcerative colitis patients: a nationwide Dutch Registry study.
    Clin Gastroenterol Hepatol. 2022 May 26. pii: S1542-3565(22)00510.
    PubMed     Abstract available


  11. OZEKI K, Tanida S, Kataoka H
    Aseptic abscess syndrome with ulcerative colitis and pyoderma gangrenosum.
    Clin Gastroenterol Hepatol. 2022 May 25. pii: S1542-3565(22)00512.
    PubMed    


  12. SCHWARTZ DA, Peyrin-Biroulet L, Lasch K, Adsul S, et al
    Efficacy and Safety of 2 Vedolizumab Intravenous Regimens for Perianal Fistulizing Crohn's Disease: ENTERPRISE Study.
    Clin Gastroenterol Hepatol. 2022;20:1059-1067.
    PubMed     Abstract available


  13. DULAI PS, Wong ECL, Reinisch W, Narula N, et al
    Clinical Decision Support Tool for Infliximab in Crohn's Disease.
    Clin Gastroenterol Hepatol. 2022;20:e1192-e1195.
    PubMed     Abstract available


  14. AHN HJ, Kim YJ, Lee HS, Park JH, et al
    High Risk of Fractures Within 7 Years of Diagnosis in Asian Patients With Inflammatory Bowel Diseases.
    Clin Gastroenterol Hepatol. 2022;20:e1022-e1039.
    PubMed     Abstract available


  15. KAWAMOTO A, Takenaka K, Hibiya S, Ohtsuka K, et al
    Serum Leucine-Rich alpha2 Glycoprotein: A Novel Biomarker For Small Bowel Mucosal Activity in Crohn's Disease.
    Clin Gastroenterol Hepatol. 2022;20:e1196-e1200.
    PubMed     Abstract available


  16. SCHAEFER M, Laurent V, Grandmougin A, Vuitton L, et al
    A Magnetic Resonance Imaging Index to Predict Crohn's Disease Postoperative Recurrence: The MONITOR Index.
    Clin Gastroenterol Hepatol. 2022;20:e1040-e1049.
    PubMed     Abstract available


  17. HUANG X, Li X
    Infliximab vs Ustekinumab in Biologic Naive Crohn's Disease.
    Clin Gastroenterol Hepatol. 2022;20:e1216.
    PubMed    


  18. QUINN KP, Urquhart SA, Janssens LP, Lennon RJ, et al
    Primary Sclerosing Cholangitis-Associated Pouchitis: A Distinct Clinical Phenotype.
    Clin Gastroenterol Hepatol. 2022;20:e964-e973.
    PubMed     Abstract available


    April 2022
  19. COHEN NA, Choi D, Choden T, Cleveland NK, et al
    Ozanimod in the Treatment of Ulcerative Colitis: Initial Real World Data from A Large Tertiary Center.
    Clin Gastroenterol Hepatol. 2022 Apr 2. pii: S1542-3565(22)00310.
    PubMed    


  20. STEINER CA, Berinstein JA, Louissaint J, Higgins PDR, et al
    Biomarkers for the Prediction and Diagnosis of Fibrostenosing Crohn's Disease: A Systematic Review.
    Clin Gastroenterol Hepatol. 2022;20:817-846.
    PubMed     Abstract available


  21. ALLOCCA M, Craviotto V, Bonovas S, Furfaro F, et al
    Predictive Value of Bowel Ultrasound in Crohn's Disease: A 12-Month Prospective Study.
    Clin Gastroenterol Hepatol. 2022;20:e723-e740.
    PubMed     Abstract available


  22. CALABRESE E, Rispo A, Zorzi F, De Cristofaro E, et al
    Ultrasonography Tight Control and Monitoring in Crohn's Disease During Different Biological Therapies: A Multicenter Study.
    Clin Gastroenterol Hepatol. 2022;20:e711-e722.
    PubMed     Abstract available


  23. BLACKWELL J, Saxena S, Jayasooriya N, Petersen I, et al
    Stoma Formation in Crohn's Disease and the Likelihood of Antidepressant Use: A Population-Based Cohort Study.
    Clin Gastroenterol Hepatol. 2022;20:e703-e710.
    PubMed     Abstract available


    March 2022
  24. SONNENBERG A, Turner KO, Saboorian H, Singhal A, et al
    The Occurrence of Gastritis in Microscopic Colitis and Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2022 Mar 23. pii: S1542-3565(22)00294.
    PubMed    


  25. ANYANE-YEBOA A, Quezada S, Rubin DT, Balzora S, et al
    The Impact of the Social Determinants of Health on Disparities in Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2022 Mar 17. pii: S1542-3565(22)00285.
    PubMed     Abstract available


  26. VEYRARD P, Pellet G, Laharie D, Nachury M, et al
    Efficacy of induction therapy with calcineurin inhibitors in combination with ustekinumab for acute severe ulcerative colitis.
    Clin Gastroenterol Hepatol. 2022 Mar 17. pii: S1542-3565(22)00282.
    PubMed    


  27. DANESE S, Sands BE, Abreu MT, O'Brien CD, et al
    Early symptomatic improvement after ustekinumab therapy in patients with ulcerative colitis: 16-week data from the UNIFI trial.
    Clin Gastroenterol Hepatol. 2022 Mar 8. pii: S1542-3565(22)00207.
    PubMed     Abstract available


  28. BEN-HORIN S, Har-Noy O, Katsanos KH, Roblin X, et al
    Corticosteroids and 5-ASA versus corticosteroids for acute severe ulcerative colitis: A randomized controlled trial.
    Clin Gastroenterol Hepatol. 2022 Mar 7. pii: S1542-3565(22)00213.
    PubMed     Abstract available


  29. TARGOWNIK LE, Bernstein CN, Benchimol EI, Kaplan GG, et al
    Earlier Anti-TNF Initiation Leads to Long Term Lower Health Care Utilization in Crohn's Disease but Not in Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2022 Mar 2. pii: S1542-3565(22)00147.
    PubMed     Abstract available


  30. PUDIPEDDI A, Paramsothy S, Leong RW
    Combination Therapy of Immunomodulators With Non-Anti-Tumor Necrosis Factor Agents in Inflammatory Bowel Disease: Need More Evidence?
    Clin Gastroenterol Hepatol. 2022;20:e640-e641.
    PubMed    


  31. ATIA O, Asayag N, Focht G, Lujan R, et al
    Perianal Crohn's Disease Is Associated With Poor Disease Outcome: A Nationwide Study From the epiIIRN Cohort.
    Clin Gastroenterol Hepatol. 2022;20:e484-e495.
    PubMed     Abstract available


  32. SANDBORN WJ, Rebuck R, Wang Y, Zou B, et al
    Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn's Disease: The IM-UNITI Trial.
    Clin Gastroenterol Hepatol. 2022;20:578-590.
    PubMed     Abstract available


  33. GUILLO L, Rabaud C, Choy EH, D'Amico F, et al
    Herpes Zoster and Vaccination Strategies in Inflammatory Bowel Diseases: A Practical Guide.
    Clin Gastroenterol Hepatol. 2022;20:481-490.
    PubMed     Abstract available


    February 2022
  34. KIM HS, Hernaez R, Sansgiry S, Waljee AK, et al
    Comparative Effectiveness of Surveillance Colonoscopy Intervals on Colorectal Cancer Outcomes in a National Cohort of Patients with Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2022 Feb 28. pii: S1542-3565(22)00205.
    PubMed     Abstract available


  35. RODRIGUEZ-DUQUE JC, Calleja JL, Iruzubieta P, Hernandez-Conde M, et al
    Increased risk of MAFLD and liver fibrosis in inflammatory bowel disease independent of classic metabolic risk factors.
    Clin Gastroenterol Hepatol. 2022 Feb 3. pii: S1542-3565(22)00093.
    PubMed     Abstract available


  36. HUANG X, Li X
    Predictive Value of Bowel Ultrasound in Crohn's Disease.
    Clin Gastroenterol Hepatol. 2022;20:e345-e346.
    PubMed    


  37. HUNTER JO
    Dietary Treatment of Crohn's Disease in Adults.
    Clin Gastroenterol Hepatol. 2022;20:e343.
    PubMed    


  38. NG A
    Maintenance Therapy in Crohn's Disease: Does the Drug Matter?
    Clin Gastroenterol Hepatol. 2022;20:472-473.
    PubMed    


  39. KAYAL M, Ungaro RC, Colombel JF
    The Chicago Classification of Pouchitis: An Important Step Toward a Needed Consensus.
    Clin Gastroenterol Hepatol. 2022;20:281-282.
    PubMed    


  40. LUCAS UEMURA K, Sousa Freitas Queiroz N, Lees CW
    What is the Real Impact of Corticosteroids in the Contemporary Treatment of Crohn's Disease?
    Clin Gastroenterol Hepatol. 2022;20:468-469.
    PubMed    


  41. SINGH S, Heien HC, Herrin J, Dulai PS, et al
    Comparative Risk of Serious Infections With Tumor Necrosis Factor alpha Antagonists vs Vedolizumab in Patients With Inflammatory Bowel Diseases.
    Clin Gastroenterol Hepatol. 2022;20:e74-e88.
    PubMed     Abstract available


  42. VANDE CASTEELE N, Abreu MT, Flier S, Papamichael K, et al
    Patients With Low Drug Levels or Antibodies to a Prior Anti-Tumor Necrosis Factor Are More Likely to Develop Antibodies to a Subsequent Anti-Tumor Necrosis Factor.
    Clin Gastroenterol Hepatol. 2022;20:465-467.
    PubMed     Abstract available


  43. BROCHARD C, Rabilloud ML, Hamonic S, Bajeux E, et al
    Natural History of Perianal Crohn's Disease: Long-term Follow-up of a Population-Based Cohort.
    Clin Gastroenterol Hepatol. 2022;20:e102-e110.
    PubMed     Abstract available


  44. KAMBOJ AK, Kane SV, Leggett CL
    Crohn's Disease of the Esophagus.
    Clin Gastroenterol Hepatol. 2022;20:A15-A16.
    PubMed    


    January 2022
  45. MAHMOUD R, Schultheiss JPD, Louwers JM, van der Kaaij MT, et al
    Immunomodulator withdrawal from anti-TNF therapy is not associated with loss of response in inflammatory bowel disease.
    Clin Gastroenterol Hepatol. 2022 Jan 28. pii: S1542-3565(22)00073.
    PubMed     Abstract available


  46. LOPES EW, Lochhead P, Burke KE, Richter JM, et al
    Risk Factors for Incident Inflammatory Bowel Disease According to Disease Phenotype.
    Clin Gastroenterol Hepatol. 2022 Jan 11. pii: S1542-3565(22)00026.
    PubMed     Abstract available


  47. FREY S, Chowdhury R, Connolly CM, Werbel WA, et al
    Antibody Response Six Months after SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2022 Jan 5. pii: S1542-3565(22)00003.
    PubMed    


  48. KAWADA T
    Stoma Formation and Antidepressant Use in Patients With Crohn's Disease.
    Clin Gastroenterol Hepatol. 2022;20:245-246.
    PubMed    


  49. HANZEL J, Ma C, Zou G, Singh S, et al
    Early Combined Immunosuppression Reduces Complications in Long-standing Crohn's Disease: A Post Hoc Analysis of REACT.
    Clin Gastroenterol Hepatol. 2022;20:236-238.
    PubMed     Abstract available


  50. HASHASH JG, Knisely MR, Germain A, McAuliff K, et al
    Brief Behavioral Therapy and Bupropion for Sleep and Fatigue in Young Adults With Crohn's Disease: An Exploratory Open Trial Study.
    Clin Gastroenterol Hepatol. 2022;20:96-104.
    PubMed     Abstract available


  51. ALMUHAIDB A, Sina J, Chen CH
    Unusual Presentation of a Crohn's Disease Patient: Not Your Typical Flare.
    Clin Gastroenterol Hepatol. 2022;20:e5-e6.
    PubMed    


    December 2021
  52. KAKUTA Y, Shirai T, McGovern DPB, Braun J, et al
    Novel diagnostic autoantibodies against Endothelial Protein C Receptor in patients with ulcerative colitis.
    Clin Gastroenterol Hepatol. 2021 Dec 28. pii: S1542-3565(21)01359.
    PubMed    


  53. LEV-TZION R, Focht G, Lujan R, Mendelovici A, et al
    COVID-19 vaccine is effective in inflammatory bowel disease patients and is not associated with disease exacerbation.
    Clin Gastroenterol Hepatol. 2021 Dec 23. pii: S1542-3565(21)01350.
    PubMed     Abstract available


  54. CHARILAOU P, Tricarico C, Battat R, Scherl EJ, et al
    Impact of Inflammatory Bowel Disease Therapies on Durability of Humoral Response to SARS CoV-2 Vaccination.
    Clin Gastroenterol Hepatol. 2021 Dec 8. pii: S1542-3565(21)01301.
    PubMed    


  55. SCHELL TL, Richard LJ, Tippins K, Russ RK, et al
    High but Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2021 Dec 8. pii: S1542-3565(21)01308.
    PubMed    


  56. BAMIAS G, Cominelli F
    Exploring the Early Phase of Crohn's Disease.
    Clin Gastroenterol Hepatol. 2021;19:2469-2480.
    PubMed     Abstract available


  57. SHAFER LA, Sofia MA, Rubin DT, Steinhart AH, et al
    An International Multicenter Comparison of IBD-Related Disability and Validation of the IBDDI.
    Clin Gastroenterol Hepatol. 2021;19:2524-2531.
    PubMed     Abstract available


    November 2021
  58. LUKIN DJ, Funez-dePagnier G, Lima S, Lai D, et al
    No Durable Impact of COVID-19 on Intestinal Disease Activity in Subjects With IBD.
    Clin Gastroenterol Hepatol. 2021;19:2312-2314.
    PubMed    


  59. DEBNATH P, Rathi P
    Treat to Target in Patients with Ileocolonic Crohn's Disease: Endoscopic Remission or Histologic Healing?
    Clin Gastroenterol Hepatol. 2021;19:2452.
    PubMed    


  60. COHEN-MEKELBURG S, Yu X, Costa D, Hofer TP, et al
    Variation in Provider Connectedness Associates With Outcomes of Inflammatory Bowel Diseases in an Analysis of Data From a National Health System.
    Clin Gastroenterol Hepatol. 2021;19:2302-2311.
    PubMed     Abstract available


    October 2021
  61. KUMAR R, Zaghiyan K, Ha C
    Lower Surgical Risks in "Contemporary" IBD Cohorts: A Reflection of Better Quality of Care or Statistics?
    Clin Gastroenterol Hepatol. 2021;19:2029-2030.
    PubMed    


  62. DEBNATH P, Rathi P
    Outcomes Related to Mucosal Healing in Patients With Crohn's Disease.
    Clin Gastroenterol Hepatol. 2021;19:2214.
    PubMed    


  63. FENSTER M, Alayo QA, Khatiwada A, Wang W, et al
    Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC Consortium.
    Clin Gastroenterol Hepatol. 2021;19:2207-2209.
    PubMed     Abstract available


  64. QIAN AS, Nguyen NH, Elia J, Ohno-Machado L, et al
    Frailty Is Independently Associated with Mortality and Readmission in Hospitalized Patients with Inflammatory Bowel Diseases.
    Clin Gastroenterol Hepatol. 2021;19:2054-2063.
    PubMed     Abstract available


  65. SCOTT FI, Hans AK, Gerich ME, Fennimore B, et al
    Identification of the Most Effective Position for Ustekinumab in Treatment Algorithms for Crohn's Disease.
    Clin Gastroenterol Hepatol. 2021;19:2082-2092.
    PubMed     Abstract available


  66. SOH H, Lee HJ, Han K, Park S, et al
    Atopic Diseases Are Associated With Development of Inflammatory Bowel Diseases in Korea: A Nationwide Population-based Study.
    Clin Gastroenterol Hepatol. 2021;19:2072-2081.
    PubMed     Abstract available


    September 2021
  67. GUPTA A, Yu A, Peyrin-Biroulet L, Ananthakrishnan AN, et al
    Treat to Target: The Role of Histologic Healing in Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis.
    Clin Gastroenterol Hepatol. 2021;19:1800-1813.
    PubMed     Abstract available


  68. PLEVRIS N, Fulforth J, Lyons M, Siakavellas SI, et al
    Normalization of Fecal Calprotectin Within 12 Months of Diagnosis Is Associated With Reduced Risk of Disease Progression in Patients With Crohn's Disease.
    Clin Gastroenterol Hepatol. 2021;19:1835-1844.
    PubMed     Abstract available


  69. HAMDEH S, Micic D, Hanauer S
    Drug-Induced Colitis.
    Clin Gastroenterol Hepatol. 2021;19:1759-1779.
    PubMed     Abstract available


    August 2021
  70. PUGLIESE D, Privitera G, Schepis T, Larosa L, et al
    Drug-related pneumonitis in patients receiving Vedolizumab therapy for Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2021 Aug 31. pii: S1542-3565(21)00921.
    PubMed    


  71. LO CH, Khandpur N, Rossato SL, Lochhead P, et al
    Ultra-processed foods and risk of Crohn's disease and ulcerative colitis: a prospective cohort study.
    Clin Gastroenterol Hepatol. 2021 Aug 27. pii: S1542-3565(21)00911.
    PubMed     Abstract available


  72. BERINSTEIN JA, Cohen-Mekelburg SA, Greenberg GM, Wray D, et al
    A Care Coordination Intervention Improves Symptoms but not Charges in High-Risk Patients with Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2021 Aug 27. pii: S1542-3565(21)00914.
    PubMed     Abstract available


  73. WONG ECL, Colombel JF, Riddell R, Marshall JK, et al
    Epithelial Neutrophilic Infiltrate - The Rising Star in Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2021 Aug 20. pii: S1542-3565(21)00904.
    PubMed    


  74. SASSON AN, Sheehan G, Yu A, Gupta A, et al
    Yield and Predictors of surveillance colonoscopies in older adults with long-standing ulcerative colitis.
    Clin Gastroenterol Hepatol. 2021 Aug 20. pii: S1542-3565(21)00899.
    PubMed     Abstract available


  75. D'SILVA A, Fox DE, Raman M
    This Letter to the Editor is in response to: Prevalence and Risk Factors for Fatigue in Adults with Inflammatory Bowel Disease/Dr. Maitreyi Raman.
    Clin Gastroenterol Hepatol. 2021 Aug 16. pii: S1542-3565(21)00874.
    PubMed    


  76. YELENCICH E, Truong E, Widaman AM, Pignotti G, et al
    Avoidant Restrictive Food Intake Disorder Prevalent among Patients with Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2021 Aug 10. pii: S1542-3565(21)00864.
    PubMed     Abstract available


  77. ESTEVINHO MM, Magro F
    Epithelial neutrophilic infiltrate - the rising star in ulcerative colitis.
    Clin Gastroenterol Hepatol. 2021 Aug 5. pii: S1542-3565(21)00835.
    PubMed    


  78. DALAL RS, McClure E, Marcus J, Winter RW, et al
    COVID-19 Vaccination Intent and Perceptions Among Patients With Inflammatory Bowel Diseases.
    Clin Gastroenterol Hepatol. 2021;19:1730-1732.
    PubMed     Abstract available


  79. YANAI H, Goren I, Godny L, Maharshak N, et al
    Early Indolent Course of Crohn's Disease in Newly Diagnosed Patients Is Not Rare and Possibly Predictable.
    Clin Gastroenterol Hepatol. 2021;19:1564-1572.
    PubMed     Abstract available


  80. DE BRUYN JR, Bossuyt P, Ferrante M, West RL, et al
    High-Dose Vitamin D Does Not Prevent Postoperative Recurrence of Crohn's Disease in a Randomized Placebo-Controlled Trial.
    Clin Gastroenterol Hepatol. 2021;19:1573-1582.
    PubMed     Abstract available


    July 2021
  81. RUDRA S, Shaul E, Conrad M, Patel T, et al
    Ruxolitinib: Targeted Approach for Treatment of Autoinflammatory Very Early Onset- Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2021 Jul 27. pii: S1542-3565(21)00822.
    PubMed    


  82. NARULA N, Wong ECL, Marshall JK, Colombel JF, et al
    Comparative Efficacy for Infliximab vs. Vedolizumab in Biologic Naive Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2021 Jul 27. pii: S1542-3565(21)00820.
    PubMed     Abstract available


  83. DAI C, Jiang M, Huang YH
    Prevalence and Risk Factors for Fatigue in Adults with Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2021 Jul 21. pii: S1542-3565(21)00759.
    PubMed    


  84. MEYER A, Taine M, Drouin J, Weill A, et al
    Serious infections in children born to mothers with inflammatory bowel disease with in utero exposure to thiopurines and anti-TNF.
    Clin Gastroenterol Hepatol. 2021 Jul 20. pii: S1542-3565(21)00760.
    PubMed     Abstract available


  85. KHAN N, Wang L, Trivedi C, Pernes T, et al
    Efficacy of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2021 Jul 15. pii: S1542-3565(21)00754.
    PubMed     Abstract available


  86. CHAN SSM, Chen Y, Casey K, Olen O, et al
    Obesity is associated with increased risk of Crohn's disease, but not ulcerative colitis: A pooled analysis of five prospective cohort studies.
    Clin Gastroenterol Hepatol. 2021 Jul 6. pii: S1542-3565(21)00720.
    PubMed     Abstract available


  87. NARULA N, Wong ECL, Colombel JF, Riddell R, et al
    Early Change in Epithelial Neutrophilic Infiltrate Predicts Long-Term Response to Biologics in Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2021 Jul 3. pii: S1542-3565(21)00716.
    PubMed     Abstract available


  88. RODRIGUEZ-LAGO I, Barreiro-de Acosta M
    Look at Both Sides of the Coin in Determining Risk of Complicated Crohn's Disease.
    Clin Gastroenterol Hepatol. 2021;19:1503-1504.
    PubMed    


  89. SEDANO R, Guizzetti L, McDonald C, Jairath V, et al
    Intravenous Ustekinumab Reinduction Is Effective in Prior Biologic Failure Crohn's Disease Patients Already on Every-4-Week Dosing.
    Clin Gastroenterol Hepatol. 2021;19:1497-1498.
    PubMed     Abstract available


  90. KAYAL M, Lambin T, Plietz M, Rizvi A, et al
    Recycling of Precolectomy Anti-Tumor Necrosis Factor Agents in Chronic Pouch Inflammation Is Associated With Treatment Failure.
    Clin Gastroenterol Hepatol. 2021;19:1491-1493.
    PubMed     Abstract available


  91. HU A, Kotze PG, Burgevin A, Tan W, et al
    Combination Therapy Does Not Improve Rate of Clinical or Endoscopic Remission in Patients with Inflammatory Bowel Diseases Treated With Vedolizumab or Ustekinumab.
    Clin Gastroenterol Hepatol. 2021;19:1366-1376.
    PubMed     Abstract available


  92. NGUYEN NH, Khera R, Ohno-Machado L, Sandborn WJ, et al
    Prevalence and Effects of Food Insecurity and Social Support on Financial Toxicity in and Healthcare Use by Patients With Inflammatory Bowel Diseases.
    Clin Gastroenterol Hepatol. 2021;19:1377-1386.
    PubMed     Abstract available


  93. MILLIEN V, Abrams D, Khalaf N
    Not All Terminal Ileitis Is Crohn's Disease: Intestinal Tuberculosis Causing Small Bowel Obstruction.
    Clin Gastroenterol Hepatol. 2021;19:e71.
    PubMed    


    June 2021
  94. D'SILVA A, Fox DE, Nasser Y, Vallance JK, et al
    Prevalence and Risk Factors for Fatigue in Adults with Inflammatory Bowel Disease: A Systematic Review with Meta-analysis.
    Clin Gastroenterol Hepatol. 2021 Jun 30. pii: S1542-3565(21)00698.
    PubMed     Abstract available


  95. ASSCHER VER, Waars SN, van der Meulen-de Jong AE, Stuyt RJL, et al
    Deficits in geriatric assessment associate with disease activity and -burden in older patients with inflammatory bowel disease.
    Clin Gastroenterol Hepatol. 2021 Jun 18. pii: S1542-3565(21)00643.
    PubMed     Abstract available


  96. CASSINOTTI A, Corona A, Duca P, Nebuloni M, et al
    NON INVASIVE MONITORING AFTER AZATHIOPRINE WITHDRAWAL IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN DEEP REMISSION.
    Clin Gastroenterol Hepatol. 2021 Jun 14. pii: S1542-3565(21)00642.
    PubMed     Abstract available


  97. DANESE S, Klopocka M, Scherl EJ, Romatowski J, et al
    Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study [102/120 characters including spaces].
    Clin Gastroenterol Hepatol. 2021 Jun 11. pii: S1542-3565(21)00614.
    PubMed     Abstract available


  98. AGRAWAL M, Brenner EJ, Yan Mak JW, Zhang X, et al
    COVID-19 outcomes among racial and ethnic minority individuals with inflammatory bowel disease in the United States.
    Clin Gastroenterol Hepatol. 2021 Jun 2. pii: S1542-3565(21)00599.
    PubMed    


  99. FAHAD H, Dulai PS, Shen B, Kochhar GS, et al
    Hyperbaric Oxygen Therapy Is Effective in the Treatment of Inflammatory and Fistulizing Pouch Complications.
    Clin Gastroenterol Hepatol. 2021;19:1288-1291.
    PubMed     Abstract available


  100. BRAGA NETO MB, Ramos GP, Loftus EV Jr, Faubion WA, et al
    Use of Immune Checkpoint Inhibitors in Patients With Pre-established Inflammatory Bowel Diseases: Retrospective Case Series.
    Clin Gastroenterol Hepatol. 2021;19:1285-1287.
    PubMed     Abstract available


  101. POUILLON L, Remen T, Amicone C, Louis E, et al
    Risk of Late Postoperative Recurrence of Crohn's Disease in Patients in Endoscopic Remission After Ileocecal Resection, Over 10 Years at Multiple Centers.
    Clin Gastroenterol Hepatol. 2021;19:1218-1225.
    PubMed     Abstract available


  102. VANDE CASTEELE N, Jairath V, Jeyarajah J, Dulai PS, et al
    Development and Validation of a Clinical Decision Support Tool That Incorporates Pharmacokinetic Data to Predict Endoscopic Healing in Patients Treated With Infliximab.
    Clin Gastroenterol Hepatol. 2021;19:1209-1217.
    PubMed     Abstract available


  103. HU AB, Tan W, Deshpande V, Ananthakrishnan AN, et al
    Ileal or Colonic Histologic Activity Is Not Associated With Clinical Relapse in Patients With Crohn's Disease in Endoscopic Remission.
    Clin Gastroenterol Hepatol. 2021;19:1226-1233.
    PubMed     Abstract available


  104. LAGRANGE J, Lacolley P, Wahl D, Peyrin-Biroulet L, et al
    Shedding Light on Hemostasis in Patients With Inflammatory Bowel Diseases.
    Clin Gastroenterol Hepatol. 2021;19:1088-1097.
    PubMed     Abstract available


    May 2021
  105. TROELSEN FS, Sorensen HT, Crockett SD, Pedersen L, et al
    Characteristics and survival of patients with inflammatory bowel disease and post-colonoscopy colorectal cancers.
    Clin Gastroenterol Hepatol. 2021 May 26. pii: S1542-3565(21)00577.
    PubMed     Abstract available


  106. BERINSTEIN JA, Sheehan J, Dias M, Berinstein EM, et al
    Tofacitinib for Biologic-Experienced Hospitalized Patients with Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study.
    Clin Gastroenterol Hepatol. 2021 May 25. pii: S1542-3565(21)00576.
    PubMed     Abstract available


  107. KAYAL M, Ungaro RC, Riggs A, Kamal K, et al
    Ileal Pouch Anal Anastomosis for the Management of Ulcerative Colitis is Associated with Significant Disability.
    Clin Gastroenterol Hepatol. 2021 May 22. pii: S1542-3565(21)00571.
    PubMed     Abstract available


  108. AHMED W, Scott FI
    Closing the gap: the real-world risk of serious infections with vedolizumab in comparison to anti-TNF therapy in inflammatory bowel disease.
    Clin Gastroenterol Hepatol. 2021 May 19. pii: S1542-3565(21)00564.
    PubMed    


  109. CONSTANT BD, Dutmer CM, Arnold MA, Hall C, et al
    Cytotoxic T-Lymphocyte-Associated Antigen 4 Haploinsufficiency Mimics Difficult to Treat Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2021 May 6. pii: S1542-3565(21)00504.
    PubMed    


  110. CON D, Van Langenberg DR, Vasudevan A
    Response to: Cumulative Exposure to Infliximab, But Not Trough Concentrations, Correlate With Rate of Infection.
    Clin Gastroenterol Hepatol. 2021;19:1077.
    PubMed    


  111. SAGAMI S, Kobayashi T, Miyatani Y, Okabayashi S, et al
    Accuracy of Ultrasound for Evaluation of Colorectal Segments in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis.
    Clin Gastroenterol Hepatol. 2021;19:908-921.
    PubMed     Abstract available


  112. BOSSUYT P, Dreesen E, Rimola J, Devuysere S, et al
    Infliximab Exposure Associates With Radiologic Evidence of Healing in Patients With Crohn's Disease.
    Clin Gastroenterol Hepatol. 2021;19:947-954.
    PubMed     Abstract available


  113. SINGER AAM, Bloom DA, Adler J
    Factors Associated With Development of Perianal Fistulas in Pediatric Patients With Crohn's Disease.
    Clin Gastroenterol Hepatol. 2021;19:1071-1073.
    PubMed     Abstract available


    April 2021
  114. CON D, Vasudevan A, van Langenberg DR
    Predictive Scores in Acute Severe Ulcerative Colitis: Which, What and When are the Decision Points We Should Target?
    Clin Gastroenterol Hepatol. 2021 Apr 24. pii: S1542-3565(21)00469.
    PubMed    


  115. VOLGER S, Scherl E
    Biologics for Inflammatory Bowel Disease and their Safety in Pregnancy.
    Clin Gastroenterol Hepatol. 2021 Apr 14. pii: S1542-3565(21)00449.
    PubMed    


  116. ROTH K, Berinstein JA
    Reply: A Patient Perspective on Contemporary Risk of Surgery in Patients with Ulcerative Colitis and Crohn's Disease.
    Clin Gastroenterol Hepatol. 2021 Apr 8. pii: S1542-3565(21)00446.
    PubMed    


  117. BHATTACHARYA S, Marciano BE, Malech HL, Quezado M, et al
    Safety and efficacy of ustekinumab in the inflammatory bowel disease of chronic granulomatous disease.
    Clin Gastroenterol Hepatol. 2021 Apr 1. pii: S1542-3565(21)00349.
    PubMed    


  118. SORRENTINO D, Geraci M, Kuballa A
    Diagnosis of Preclinical Crohn's Disease: Hurdles, Challenges, and Hopes.
    Clin Gastroenterol Hepatol. 2021;19:857-858.
    PubMed    


  119. YZET C, Diouf M, Singh S, Brazier F, et al
    No Benefit of Concomitant Immunomodulator Therapy on Efficacy of Biologics That Are Not Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases: A Meta-analysis.
    Clin Gastroenterol Hepatol. 2021;19:668-679.
    PubMed     Abstract available


  120. SIGALL BONEH R, Van Limbergen J, Wine E, Assa A, et al
    Dietary Therapies Induce Rapid Response and Remission in Pediatric Patients With Active Crohn's Disease.
    Clin Gastroenterol Hepatol. 2021;19:752-759.
    PubMed     Abstract available


  121. RIVIERE P, Vermeire S, Irles-Depe M, Van Assche G, et al
    Rates of Postoperative Recurrence of Crohn's Disease and Effects of Immunosuppressive and Biologic Therapies.
    Clin Gastroenterol Hepatol. 2021;19:713-720.
    PubMed     Abstract available


  122. JESSEN B, Rodriguez-Sillke Y, Sonnenberg E, Schumann M, et al
    Level of Tumor Necrosis Factor Production by Stimulated Blood Mononuclear Cells Can Be Used to Predict Response of Patients With Inflammatory Bowel Diseases to Infliximab.
    Clin Gastroenterol Hepatol. 2021;19:721-731.
    PubMed     Abstract available


  123. BARNES EL, Kochar B, Herfarth HH, Winter RW, et al
    Creation of a Case-Finding Definition for Identifying Patients With Acute Pouchitis in Administrative Claims Data.
    Clin Gastroenterol Hepatol. 2021;19:842-844.
    PubMed     Abstract available


    March 2021
  124. AHMED W, Galati J, Kumar A, Christos PJ, et al
    Dual Biologic or Small Molecule Therapy for Treatment of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Clin Gastroenterol Hepatol. 2021 Mar 30. pii: S1542-3565(21)00344.
    PubMed     Abstract available


  125. LOPES EW, Lebwohl B, Burke KE, Ivey KL, et al
    DIETARY GLUTEN INTAKE IS NOT ASSOCIATED WITH RISK OF INFLAMMATORY BOWEL DISEASE IN U.S. ADULTS WITHOUT CELIAC DISEASE.
    Clin Gastroenterol Hepatol. 2021 Mar 25. pii: S1542-3565(21)00339.
    PubMed     Abstract available


  126. DALAL RS, Esckilsen S, Barnes EL, Pruce JC, et al
    Predictors and outcomes of ustekinumab dose intensification in ulcerative colitis: a multicenter cohort study.
    Clin Gastroenterol Hepatol. 2021 Mar 25. pii: S1542-3565(21)00338.
    PubMed    


  127. NAMBU R, Warner N, Mulder DJ, Kotlarz D, et al
    A Systematic Review of Monogenic Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2021 Mar 18. pii: S1542-3565(21)00331.
    PubMed     Abstract available


  128. OKAMOTO T, Fukuda K
    Long-term outcomes in asymptomatic ulcerative colitis diagnosed during screening colonoscopy.
    Clin Gastroenterol Hepatol. 2021 Mar 11. pii: S1542-3565(21)00275.
    PubMed    


  129. SANDBORN WJ, Peyrin-Biroulet L, Sharara AI, Su C, et al
    Efficacy and Safety of Tofacitinib in Ulcerative Colitis Based on Prior Tumor Necrosis Factor Inhibitor Failure Status.
    Clin Gastroenterol Hepatol. 2021 Mar 5. pii: S1542-3565(21)00222.
    PubMed     Abstract available


  130. ALAMEEL T, Al Sulais E
    Risk of HBV Reactivation Among IBD patients With Occult Hepatitis B Virus Infection.
    Clin Gastroenterol Hepatol. 2021;19:621-622.
    PubMed    


  131. ANANTHAKRISHNAN AN, Deshpande V
    It Is All in the Fine Print: A Call for a Histopathology Checklist for IBD.
    Clin Gastroenterol Hepatol. 2021;19:446-447.
    PubMed    


  132. TANDON P, Malhi G, Abdali D, Pogue E, et al
    Active Margins, Plexitis, and Granulomas Increase Postoperative Crohn's Recurrence: Systematic Review and Meta-analysis.
    Clin Gastroenterol Hepatol. 2021;19:451-462.
    PubMed     Abstract available


  133. BORREN NZ, Plichta D, Joshi AD, Bonilla G, et al
    Alterations in Fecal Microbiomes and Serum Metabolomes of Fatigued Patients With Quiescent Inflammatory Bowel Diseases.
    Clin Gastroenterol Hepatol. 2021;19:519-527.
    PubMed     Abstract available


  134. SASSON AN, Ananthakrishnan AN, Raman M
    Diet in Treatment of Inflammatory Bowel Diseases.
    Clin Gastroenterol Hepatol. 2021;19:425-435.
    PubMed     Abstract available


    February 2021
  135. AKHTAR HJ, Nguyen TM, Ma C, Jairath V, et al
    Vedolizumab for the treatment of Non-Inflammatory Bowel Disease Related Enteropathy.
    Clin Gastroenterol Hepatol. 2021 Feb 19. pii: S1542-3565(21)00204.
    PubMed    


  136. JANGI S, Holmer AK, Dulai PS, Boland B, et al
    Spatial Evolution of Histologic and Endoscopic Healing in Left and Right Colon in Patients with Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2021 Feb 5. pii: S1542-3565(21)00108.
    PubMed     Abstract available


  137. AKIYAMA S, Ollech JE, Rai V, Glick LR, et al
    Endoscopic phenotype of the J pouch in patients with inflammatory bowel disease: A new classification for pouch outcomes.
    Clin Gastroenterol Hepatol. 2021 Feb 4. pii: S1542-3565(21)00111.
    PubMed     Abstract available


  138. LONG MD, Siegel CA, Abraham BP, Chiorean M, et al
    Day Care Attendance and Infectious Complications in Children Born to Mothers with Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2021 Feb 4. pii: S1542-3565(21)00104.
    PubMed    


  139. FALECK DM, Shmidt E, Huang R, Katta LG, et al
    Effect of Concomitant Therapy With Steroids and Tumor Necrosis Factor Antagonists for Induction of Remission in Patients With Crohn's Disease: A Systematic Review and Pooled Meta-analysis.
    Clin Gastroenterol Hepatol. 2021;19:238-245.
    PubMed     Abstract available


  140. BOLAND K, Bedrani L, Turpin W, Kabakchiev B, et al
    Persistent Diarrhea in Patients With Crohn's Disease After Mucosal Healing Is Associated With Lower Diversity of the Intestinal Microbiome and Increased Dysbiosis.
    Clin Gastroenterol Hepatol. 2021;19:296-304.
    PubMed     Abstract available


  141. LANDEMAINE A, Petitcollin A, Brochard C, Miard C, et al
    Cumulative Exposure to Infliximab, But Not Trough Concentrations, Correlates With Rate of Infection.
    Clin Gastroenterol Hepatol. 2021;19:288-295.
    PubMed     Abstract available


    January 2021
  142. LAURAIN PA, Guillo L, D'Amico F, Netter P, et al
    Incidence of and risk factors for colorectal strictures in ulcerative colitis: a multicenter study.
    Clin Gastroenterol Hepatol. 2021 Jan 22. pii: S1542-3565(21)00078.
    PubMed     Abstract available


  143. VAN DER SLOOT KWJ, Tiems JL, Visschedijk MC, Festen EAM, et al
    Cigarette smoke increases risk for colorectal neoplasia in inflammatory bowel disease.
    Clin Gastroenterol Hepatol. 2021 Jan 13. pii: S1542-3565(21)00018.
    PubMed     Abstract available


  144. DAI C, Huang YH, Jiang M
    Two Types of Fecal Tests in Patients With Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2021;19:209.
    PubMed    


  145. DEL HOYO J, Aguas M
    Cost-effectiveness of Telemedicine-directed Specialized vs Standard Care for Patients With Inflammatory Bowel Diseases in a Randomized Trial.
    Clin Gastroenterol Hepatol. 2021;19:206-207.
    PubMed    


  146. BRENNER EJ, Kappelman MD
    Working Together to Meet the Needs of Patients With Inflammatory Bowel Diseases.
    Clin Gastroenterol Hepatol. 2021;19:210-211.
    PubMed    


  147. NAGANUMA M, Kanai T
    Reply.
    Clin Gastroenterol Hepatol. 2021;19:209-210.
    PubMed    


  148. LO CH, Khalili H, Song M, Lochhead P, et al
    Healthy Lifestyle Is Associated With Reduced Mortality in Patients With Inflammatory Bowel Diseases.
    Clin Gastroenterol Hepatol. 2021;19:87-95.
    PubMed     Abstract available


  149. OLLECH JE, Normatov I, Peleg N, Wang J, et al
    Effectiveness of Ustekinumab Dose Escalation in Patients With Crohn's Disease.
    Clin Gastroenterol Hepatol. 2021;19:104-110.
    PubMed     Abstract available


  150. HANZEL J, Zdovc J, Kurent T, Sever N, et al
    Peak Concentrations of Ustekinumab After Intravenous Induction Therapy Identify Patients With Crohn's Disease Likely to Achieve Endoscopic and Biochemical Remission.
    Clin Gastroenterol Hepatol. 2021;19:111-118.
    PubMed     Abstract available


    December 2020
  151. KIRCHGESNER J, Desai RJ, Beaugerie L, Schneeweiss S, et al
    Risk of serious infections with vedolizumab versus tumor necrosis factor antagonists in patients with inflammatory bowel disease.
    Clin Gastroenterol Hepatol. 2020 Dec 30. pii: S1542-3565(20)31726.
    PubMed     Abstract available


  152. GUILLO L, Uzzan M, Beaugerie L, Gornet JM, et al
    Impact of HIV infection on the course of inflammatory bowel disease and drug safety profile: a multicenter GETAID study.
    Clin Gastroenterol Hepatol. 2020 Dec 24. pii: S1542-3565(20)31719.
    PubMed     Abstract available


  153. KHANNA R, Ma C, Jairath V, Casteele NV, et al
    Endoscopic Assessment of Inflammatory Bowel Disease Activity in Clinical Trials.
    Clin Gastroenterol Hepatol. 2020 Dec 15. pii: S1542-3565(20)31674.
    PubMed     Abstract available


  154. MA C, Jeyarajah J, Guizzetti L, Parker CE, et al
    Modeling Endoscopic Improvement after Induction Treatment with Mesalamine in Patients with Mild-to-Moderate Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2020 Dec 3. pii: S1542-3565(20)31630.
    PubMed     Abstract available


    November 2020
  155. WANG CY, Chen WL, Cheng-Chung Wei J
    Link Between Inflammatory Bowel Disease and Risk of Chronic Kidney Disease.
    Clin Gastroenterol Hepatol. 2020 Nov 21. pii: S1542-3565(20)31498.
    PubMed    


  156. VAJRAVELU RK, Copelovitch L, Denburg MR
    Letter title: "Link between inflammatory bowel disease and risk of chronic kidney disease" by Wang and colleagues.
    Clin Gastroenterol Hepatol. 2020 Nov 20. pii: S1542-3565(20)31565.
    PubMed    


  157. BRAAT H, Parikh K, Peppelenbosch MP
    Complete Resolution of Mucosal Neutrophils May Predict Non-fatigue in Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2020 Nov 19. pii: S1542-3565(20)31559.
    PubMed    


  158. GRACIE DJ, Ford AC
    Bugs and the Brain in Inflammatory Bowel Disease: A Novel Treatment Target?
    Clin Gastroenterol Hepatol. 2020 Nov 6. pii: S1542-3565(20)31434.
    PubMed    


  159. D'AMICO F, Danese S, Peyrin-Biroulet L
    Systematic Review on Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: It Is Time to Take Stock.
    Clin Gastroenterol Hepatol. 2020;18:2689-2700.
    PubMed     Abstract available


    October 2020
  160. SANDBORN WJ, Peyrin-Biroulet L, Quirk D, Wang W, et al
    Efficacy and Safety of Extended Induction with Tofacitinib for the Treatment of Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2020 Oct 27. pii: S1542-3565(20)31496.
    PubMed     Abstract available


  161. TSAI L, Ma C, Dulai PS, Prokop LJ, et al
    Contemporary Risk of Surgery in Patients with Ulcerative Colitis and Crohn's Disease: A Meta-Analysis of Population-based Cohorts.
    Clin Gastroenterol Hepatol. 2020 Oct 27. pii: S1542-3565(20)31497.
    PubMed     Abstract available


  162. OLLECH JE, Avni-Biron I, Glick L, Haider H, et al
    Effective Treatment of Acute Severe Ulcerative Colitis in Pregnancy Is Associated with Good Maternal and Fetal Outcomes.
    Clin Gastroenterol Hepatol. 2020 Oct 22. pii: S1542-3565(20)31493.
    PubMed     Abstract available


  163. LI YM, Stettler I, Oungpasuk K
    Association Between Provider Connectedness and Inflammatory Bowel Disease Outcomes.
    Clin Gastroenterol Hepatol. 2020 Oct 22. pii: S1542-3565(20)31291.
    PubMed    


  164. STEENHOLDT C, Jensen JT, Brynskov J, Moller AM, et al
    Patient Satisfaction of Propofol Versus Midazolam and Fentanyl Sedation During Colonoscopy in Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2020 Oct 22. pii: S1542-3565(20)31495.
    PubMed     Abstract available


  165. VEDAMURTHY A, Gangasani N, Ananthakrishnan AN
    Vedolizumab or TNF-antagonist use and risk of new or recurrent cancer in patients with inflammatory bowel disease with prior malignancy: A retrospective cohort study.
    Clin Gastroenterol Hepatol. 2020 Oct 13. pii: S1542-3565(20)31396.
    PubMed     Abstract available


  166. KHOUDARI G, Mansoor E, Click B, Alkhayyat M, et al
    Rates of Intestinal Resection and Colectomy in Inflammatory Bowel Disease Patients after Initiation of Biologics: A Cohort Study.
    Clin Gastroenterol Hepatol. 2020 Oct 13. pii: S1542-3565(20)31397.
    PubMed     Abstract available


  167. NAESSENS D, Cameron C, Hoaglin DC
    Network Meta-Analysis of Ulcerative Colitis Pharmacotherapies: Carryover Effects from Induction and Bias of the Results.
    Clin Gastroenterol Hepatol. 2020 Oct 13. pii: S1542-3565(20)31428.
    PubMed    


  168. BRENNER EJ, Pigneur B, Focht G, Zhang X, et al
    BENIGN EVOLUTION OF SARS-CoV2 INFECTIONS IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM TWO INTERNATIONAL DATABASES.
    Clin Gastroenterol Hepatol. 2020 Oct 12. pii: S1542-3565(20)31399.
    PubMed    


  169. COLOMBEL JF, Osterman MT, Thorpe AJ, Salese L, et al
    Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2020 Oct 8. pii: S1542-3565(20)31389.
    PubMed     Abstract available


  170. LUKIN D, Faleck D, Xu R, Zhang Y, et al
    Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2020 Oct 8. pii: S1542-3565(20)31388.
    PubMed     Abstract available


    September 2020
  171. KIM HJ, Shah SC, Hann HJ, Kazmi SZ, et al
    Familial Risk of Inflammatory Bowel Disease - A Population-based Cohort study in South Korea.
    Clin Gastroenterol Hepatol. 2020 Sep 30. pii: S1542-3565(20)31384.
    PubMed     Abstract available


  172. DIMKE H, Winther-Jensen M, Allin KH, Lund L, et al
    Risk of Urolithiasis in Patients with Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2020 Sep 29. pii: S1542-3565(20)31379.
    PubMed     Abstract available


  173. SANDBORN WJ, Ferrante M, Bhandari BR, Berliba E, et al
    Efficacy and Safety of Continued Treatment with Mirikizumab in a Phase 2 Trial of Patients with Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2020 Sep 17. pii: S1542-3565(20)31289.
    PubMed     Abstract available


  174. NIELSEN OH, Gubatan JM, Juhl CB, Streett SE, et al
    Biologics for Inflammatory Bowel Disease and their Safety in Pregnancy: A Systematic Review and Meta-analysis.
    Clin Gastroenterol Hepatol. 2020 Sep 12. pii: S1542-3565(20)31281.
    PubMed     Abstract available


  175. MAGRO F, Alves C, Lopes J, Lopes S, et al
    Histologic Features of Colon Biopsies (Geboes Score) Associated With Progression of Ulcerative Colitis for the First 36 Months After Biopsy.
    Clin Gastroenterol Hepatol. 2020 Sep 10. pii: S1542-3565(20)31274.
    PubMed     Abstract available


  176. FAIRBRASS KM, Gracie DJ
    Mood and Treatment Persistence in Inflammatory Bowel Disease: Time to Consider Integrated Models of Care?
    Clin Gastroenterol Hepatol. 2020 Sep 1. pii: S1542-3565(20)31227.
    PubMed    


    August 2020
  177. STORAN D, Doherty GA, Cullen G
    Ustekinumab 90 mg Every 2 Weeks for the Treatment of Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2020 Aug 30. pii: S1542-3565(20)31079.
    PubMed    


  178. NICCUM B, Moninuola O, Miller K, Khalili H, et al
    Opioid use among patients with inflammatory bowel disease: A systematic review and meta-analysis.
    Clin Gastroenterol Hepatol. 2020 Aug 21. pii: S1542-3565(20)31150.
    PubMed     Abstract available


  179. PAPA A, Lopetuso LR, Tursi A
    Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: The Picture Is Taking Shape.
    Clin Gastroenterol Hepatol. 2020 Aug 18. pii: S1542-3565(20)31142.
    PubMed    


  180. GILMORE R, Hilley P, Srinivasan A, Choy MC, et al
    Tofacitinib is Safe and Effective When Used in Combination With Infliximab for the Management of Refractory Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2020 Aug 16. pii: S1542-3565(20)31008.
    PubMed    


  181. LO B, Zhao M, Vind I, Burisch J, et al
    The risk of extra-intestinal cancer in inflammatory bowel disease: a systematic review and meta-analysis of population-based cohort studies.
    Clin Gastroenterol Hepatol. 2020 Aug 12. pii: S1542-3565(20)31124.
    PubMed     Abstract available


  182. STEVENS TW, Gecse K, Turner JR, de Hertogh G, et al
    Diagnostic Accuracy of Fecal Calprotectin Concentration in Evaluating Therapeutic Outcomes of Patients With Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2020 Aug 12. pii: S1542-3565(20)31128.
    PubMed     Abstract available


  183. BERINSTEIN JA, Steiner CA, Higgins PDR
    Reply to Tofacitinib is safe and effective when used in combination with Infliximab for the management of Refractory Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2020 Aug 12. pii: S1542-3565(20)31132.
    PubMed    


  184. LAHARIE D, Bourreille A, Branche J, Allez M, et al
    Evolution of endoscopic lesions in steroid-refractory acute severe ulcerative colitis responding to infliximab or cyclosporine.
    Clin Gastroenterol Hepatol. 2020 Aug 7. pii: S1542-3565(20)31078.
    PubMed     Abstract available


    July 2020
  185. AREBI N, Dyall L, Kamperidis N
    A User's Guide to De-Escalating Immunomodulator and Biologic Therapy in Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2020 Jul 27. pii: S1542-3565(20)30920.
    PubMed    


  186. CHHIBBA T, Guizzetti L, Seow CH, Lu C, et al
    Frequency of Opioid Prescription at Emergency Department Discharge in Patients with Inflammatory Bowel Disease: A Nationwide Analysis (2006-2017).
    Clin Gastroenterol Hepatol. 2020 Jul 16. pii: S1542-3565(20)30982.
    PubMed     Abstract available


  187. DOLOVICH C, Bernstein CN, Singh H, Nugent Z, et al
    Anxiety and Depression Leads to Anti-Tumor Necrosis Factor Discontinuation in Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2020 Jul 12. pii: S1542-3565(20)30974.
    PubMed     Abstract available


  188. DEEPAK P, Alayo QA, Khatiwada A, Lin B, et al
    Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2020 Jul 3. pii: S1542-3565(20)30913.
    PubMed     Abstract available


    June 2020
  189. HWANG C, Issokson K, Giguere-Rich C, Reddy S, et al
    Development and Pilot Testing of the Inflammatory Bowel Disease Nutrition Care Pathway.
    Clin Gastroenterol Hepatol. 2020 Jun 26. pii: S1542-3565(20)30902.
    PubMed    


  190. SCAIOLI E, Salice M, Belluzzi A
    Omega-3 as a Part of the Dietary Guidance for Patients with Ulcerative Colitis: Beyond the Natural Sources.
    Clin Gastroenterol Hepatol. 2020 Jun 25. pii: S1542-3565(20)30760.
    PubMed    


  191. BARNES EL, Herfarth HH, Kappelman MD, Zhang X, et al
    Incidence, Risk Factors, and Outcomes of Pouchitis and Pouch-related Complications in Patients with Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2020 Jun 22. pii: S1542-3565(20)30846.
    PubMed     Abstract available


  192. CARON B, Arondel Y, Reimund JM
    Covid-19 and inflammatory bowel disease: questions on incidence, severity, and impact of treatment?
    Clin Gastroenterol Hepatol. 2020 Jun 6. pii: S1542-3565(20)30764.
    PubMed    


  193. PAPAMICHAEL K, Cheifetz AS
    Therapeutic Drug Monitoring and Safety of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2020 Jun 5. pii: S1542-3565(20)30638.
    PubMed    


    May 2020
  194. FRITSCH J, Garces L, Quintero MA, Pignac-Kobinger J, et al
    Low-fat, High-fiber Diet Reduces Markers of Inflammation and Dysbiosis and Improves Quality of Life in Patients With Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2020 May 20. pii: S1542-3565(20)30685.
    PubMed     Abstract available


  195. MELNYK J, Stefanov DG, Sultan K
    Inflammatory Bowel Disease and Corticosteroid induced Diabetes Mellitus.
    Clin Gastroenterol Hepatol. 2020 May 17. pii: S1542-3565(20)30678.
    PubMed    


  196. DULAI PS, Sandborn WJ, Murphy J
    Microsimulation Model to Determine the Cost Effectiveness of Treat to Target Strategies for Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2020 May 10. pii: S1542-3565(20)30644.
    PubMed     Abstract available


  197. CHENG D, Cushing KC, Cai T, Ananthakrishnan AN, et al
    Safety and Efficacy of Tumor Necrosis Factor Antagonists in Older Patients With Ulcerative Colitis: Patient-Level Pooled Analysis of Data From Randomized Trials.
    Clin Gastroenterol Hepatol. 2020 May 1. pii: S1542-3565(20)30615.
    PubMed     Abstract available


  198. FOTEINOGIANNOPOULOU K, Orfanoudaki E, Koutroubakis IE
    Keeping on the high quality of healthcare in Greek Inflammatory Bowel Disease patients in the SARS-CoV-2 era.
    Clin Gastroenterol Hepatol. 2020 May 1. pii: S1542-3565(20)30621.
    PubMed    


    April 2020
  199. ALLOCCA M, Fiorino G, Zallot C, Furfaro F, et al
    Incidence and patterns of COVID-19 among inflammatory bowel disease patients from the Nancy and Milan cohorts.
    Clin Gastroenterol Hepatol. 2020 Apr 30. pii: S1542-3565(20)30616.
    PubMed    


  200. EL-MATARY W, Guthery SL, Amir AZ, DiGuglielmo M, et al
    Colorectal Dysplasia and Cancer in Pediatric-onset Ulcerative Colitis Associated with Primary Sclerosing Cholangitis.
    Clin Gastroenterol Hepatol. 2020 Apr 29. pii: S1542-3565(20)30600.
    PubMed    


  201. BATTAT R, Hemperly A, Truong S, Whitmire N, et al
    Baseline Clearance of Infliximab is Associated with Requirement for Colectomy in Patients with Acute Severe Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2020 Apr 26. pii: S1542-3565(20)30530.
    PubMed     Abstract available


  202. HANZEL J, Ma C, Marshall JK, Feagan BG, et al
    Managing Inflammatory Bowel Disease During COVID-19: Summary of Recommendations from Gastrointestinal Societies.
    Clin Gastroenterol Hepatol. 2020 Apr 21. pii: S1542-3565(20)30529.
    PubMed    


  203. ALLOCCA M, Fiorino G, Furfaro F, Gilardi D, et al
    Maintaining the quality standards of care for inflammatory bowel disease patients during the COVID-19 pandemic.
    Clin Gastroenterol Hepatol. 2020 Apr 15. pii: S1542-3565(20)30524.
    PubMed    


  204. LAI SW, Kuo YH, Liao KF
    Association Between Inflammatory Bowel Disease and Diabetes Mellitus.
    Clin Gastroenterol Hepatol. 2020;18:1002-1003.
    PubMed    


  205. ONA S, Long M, Mitchell C
    Reply.
    Clin Gastroenterol Hepatol. 2020;18:1002.
    PubMed    


    March 2020
  206. MUIR AJ
    What Clues Can We Use From Primary Sclerosing Cholangitis With Inflammatory Bowel Disease Phenotypes?
    Clin Gastroenterol Hepatol. 2020 Mar 30. pii: S1542-3565(20)30430.
    PubMed    


  207. PAPAMICHAEL K, Clarke WT, Casteele NV, Germansky KA, et al
    Comparison between assays used for therapeutic drug monitoring of infliximab and adalimumab in inflammatory bowel disease.
    Clin Gastroenterol Hepatol. 2020 Mar 5. pii: S1542-3565(20)30273.
    PubMed    


    February 2020
  208. NITTALA R, Singh A
    Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients with Active Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2020 Feb 25. pii: S1542-3565(20)30208.
    PubMed    


  209. SONNENBERG A, Turner KO, Genta RM
    Comorbid Occurrence of Eosinophilic Esophagitis and Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2020 Feb 14. pii: S1542-3565(20)30183.
    PubMed    


  210. LEVINE A, Rhodes JM, Lindsay JO, Abreu MT, et al
    Dietary Guidance for Patients with Inflammatory Bowel Disease from the International Organization for the Study of Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2020 Feb 14. pii: S1542-3565(20)30185.
    PubMed     Abstract available


  211. KWAPISZ L, Raffals LE, Bruining DH, Pardi DS, et al
    Combination Biologic Therapy in Inflammatory Bowel Disease: Experience from a Tertiary Care Center.
    Clin Gastroenterol Hepatol. 2020 Feb 14. pii: S1542-3565(20)30186.
    PubMed    


  212. DULAI PS, Singh S, Casteele NV, Meserve J, et al
    Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2020 Feb 13. pii: S1542-3565(20)30174.
    PubMed     Abstract available


  213. PANSART C, Roblin X, Paul S
    Preanalytical Heterogeneity in Fecal Calprotectin Measurement Needs To Be Considered for Tight Control.
    Clin Gastroenterol Hepatol. 2020;18:524-525.
    PubMed    


  214. KENNEDY NA, Lees CW
    Reply.
    Clin Gastroenterol Hepatol. 2020;18:526.
    PubMed    


  215. COZIJNSEN MA, Turner D
    Reply.
    Clin Gastroenterol Hepatol. 2020;18:525-526.
    PubMed    


    January 2020
  216. MAGRO F, Estevinho MM
    Do Neutrophils Contribute to Development of Crohn's Disease and Ulcerative Colitis?"
    Clin Gastroenterol Hepatol. 2020 Jan 30. pii: S1542-3565(20)30111.
    PubMed    


  217. LORES T, Goess C, Mikocka-Walus A, Collins KL, et al
    Integrated Psychological Care Reduces Healthcare Costs at a Hospital-Based Inflammatory Bowel Disease Service.
    Clin Gastroenterol Hepatol. 2020 Jan 30. pii: S1542-3565(20)30109.
    PubMed     Abstract available


  218. MA C, Smith M, Guizzetti L, Panaccione R, et al
    Assessing National Trends and Disparities in Ambulatory, Emergency Department, and Inpatient Visits for Inflammatory Bowel Disease in the United States (2005-2016).
    Clin Gastroenterol Hepatol. 2020 Jan 24. pii: S1542-3565(20)30102.
    PubMed     Abstract available


  219. DANESE S, Fiorino G, Peyrin-Biroulet L
    Positioning therapies in ulcerative colitis.
    Clin Gastroenterol Hepatol. 2020 Jan 23. pii: S1542-3565(20)30096.
    PubMed     Abstract available


  220. SINGH S, Murad MH, Fumery M, Dulai PS, et al
    First- and Second-line Pharmacotherapies for Patients with Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis.
    Clin Gastroenterol Hepatol. 2020 Jan 13. pii: S1542-3565(20)30044.
    PubMed     Abstract available


  221. LE BAUT G, Kirchgesner J, Amiot A, Lefevre JH, et al
    A Scoring System to Determine Patients' Risk of Colectomy Within 1 y After Hospital Admission for Acute Severe Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2020 Jan 9. pii: S1542-3565(20)30029.
    PubMed     Abstract available


  222. KAUR M, Dalal RL, Shaffer S, Schwartz DA, et al
    Inpatient Management of Inflammatory Bowel Disease Related Complications.
    Clin Gastroenterol Hepatol. 2020 Jan 9. pii: S1542-3565(20)30034.
    PubMed     Abstract available


  223. DANESE S, Neurath MF, Kopon A, Zakko SF, et al
    Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2020 Jan 8. pii: S1542-3565(20)30005.
    PubMed     Abstract available


  224. RODA G, Lleo A, Danese S, Aghemo A, et al
    All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing Cholangitis.
    Clin Gastroenterol Hepatol. 2020;18:51-53.
    PubMed    


  225. DREESEN E, Gils A
    Reply.
    Clin Gastroenterol Hepatol. 2020;18:262-263.
    PubMed    


  226. DAI C, Jiang M, Sun MJ
    Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's Disease.
    Clin Gastroenterol Hepatol. 2020;18:262.
    PubMed    


    December 2019
  227. HIRTEN RP, Lakatos PL, Halfvarson J, Colombel JF, et al
    A Users Guide to De-escalating Immunomodulator and Biologic Therapy in Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2019 Dec 27. pii: S1542-3565(19)31499.
    PubMed     Abstract available


  228. SIEGEL CA, Thompson KD, Walls D, Gollins J, et al
    Crohn's disease patients' and gastroenterologists' perspectives towards de-escalating inflammatory bowel disease therapy.
    Clin Gastroenterol Hepatol. 2019 Dec 27. pii: S1542-3565(19)31498.
    PubMed    


  229. PAI RK, Hartman DJ, Rivers CR, Regueiro M, et al
    Complete Resolution of Mucosal Neutrophils Associates With Improved Long-Term Clinical Outcomes of Patients With Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019 Dec 13. pii: S1542-3565(19)31438.
    PubMed     Abstract available


  230. ADEDOKUN OJ, Xu Z, Marano C, O'Brien C, et al
    Ustekinumab Pharmacokinetics and Exposure Response in a Phase 3 Randomized Trial of Patients With Ulcerative Colitis: Ustekinumab PK and exposure-response in UC.
    Clin Gastroenterol Hepatol. 2019 Dec 6. pii: S1542-3565(19)31403.
    PubMed     Abstract available


  231. LAI SW
    Herpes Zoster Vaccine in Older Adults With Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2019;17:2823.
    PubMed    


    November 2019
  232. BERGQUIST A, Stokkeland K, Bottai M, Soderberg-Lofdal K, et al
    Reply - Associations between drug exposure and outcomes in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Clin Gastroenterol Hepatol. 2019 Nov 12. pii: S1542-3565(19)31276.
    PubMed    


    October 2019
  233. VILLUMSEN M, Jess T, Allin KH
    Association between inflammatory bowel disease and diabetes mellitus - study population matters.
    Clin Gastroenterol Hepatol. 2019 Oct 10. pii: S1542-3565(19)31104.
    PubMed    


  234. FUNG BM, Ali AH, Tabibian JH
    Associations between drug exposure and outcomes in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Clin Gastroenterol Hepatol. 2019 Oct 5. pii: S1542-3565(19)31095.
    PubMed    


  235. BARNES EL, Lightner AL, Regueiro M
    Peri-operative and Post-operative Management of Patients with Crohn's Disease and Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019 Oct 4. pii: S1542-3565(19)31091.
    PubMed     Abstract available


    September 2019
  236. MA C, Sandborn WJ, D'Haens GR, Zou G, et al
    Discordance Between Patient-Reported Outcomes and Mucosal Inflammation in Patients With Mild to Moderate Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019 Sep 20. pii: S1542-3565(19)31027.
    PubMed     Abstract available


    June 2019
  237. KHALILI H
    Reply.
    Clin Gastroenterol Hepatol. 2019;17:1418-1419.
    PubMed    


  238. YANG XY, Chen PF, He JH
    High Consumption of Sweetened Beverages Might Increase the Risk of Inflammatory Bowel Diseases.
    Clin Gastroenterol Hepatol. 2019;17:1417-1418.
    PubMed    


    May 2019
  239. LAHARIE D, Pellet G
    Reply.
    Clin Gastroenterol Hepatol. 2019;17:1214-1215.
    PubMed    


    March 2019
  240. ANIWAN S, Loftus EV Jr
    Reply.
    Clin Gastroenterol Hepatol. 2019;17:800-801.
    PubMed    


  241. HIRTEN RP, Ghosh S, Colombel JF
    Reply.
    Clin Gastroenterol Hepatol. 2019;17:796-797.
    PubMed    


  242. LE BERRE C, Loeuille D, Peyrin-Biroulet L
    Combination Therapy With Vedolizumab and Tofacitinib in a Patient With Ulcerative Colitis and Spondyloarthropathy.
    Clin Gastroenterol Hepatol. 2019;17:794-796.
    PubMed    


    February 2019
  243. JOHNSON C, Binion DG
    Reply.
    Clin Gastroenterol Hepatol. 2019;17:576.
    PubMed    


  244. COLOMBEL JF, Shin A, Gibson PR
    Reply.
    Clin Gastroenterol Hepatol. 2019;17:573-574.
    PubMed    


  245. PARDI DS, Cotter TG, Loftus EV Jr
    Reply.
    Clin Gastroenterol Hepatol. 2019;17:572.
    PubMed    


  246. DULAI PS, Peyrin-Biroulet L
    Integrating Patient-Reported Outcomes Into Treat-to-Target Monitoring Algorithms.
    Clin Gastroenterol Hepatol. 2019;17:395-396.
    PubMed    


  247. VAN KRUININGEN HJ, Sura R
    Erroneous Use of Endoscopic Biopsy Data in Crohn's Disease.
    Clin Gastroenterol Hepatol. 2019;17:575-576.
    PubMed    


  248. MACALUSO FS, Cottone M, Orlando A
    Risk of Pneumonia Caused by Pneumocystis jiroveci in Inflammatory Bowel Disease: The Role of Concomitant Pulmonary Comorbidities.
    Clin Gastroenterol Hepatol. 2019;17:571-572.
    PubMed    


  249. COLOMBEL JF, Shin A, Gibson PR
    AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review.
    Clin Gastroenterol Hepatol. 2019;17:380-390.
    PubMed     Abstract available


  250. BEAUGERIE L, Kirchgesner J
    Balancing Benefit vs Risk of Immunosuppressive Therapy for Individual Patients With Inflammatory Bowel Diseases.
    Clin Gastroenterol Hepatol. 2019;17:370-379.
    PubMed     Abstract available


  251. NALAGATLA N, Falloon K, Tran G, Borren NZ, et al
    Effect of Accelerated Infliximab Induction on Short- and Long-term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta-analysis.
    Clin Gastroenterol Hepatol. 2019;17:502-509.
    PubMed     Abstract available


  252. NARULA N, Alshahrani AA, Yuan Y, Reinisch W, et al
    Patient-Reported Outcomes and Endoscopic Appearance of Ulcerative Colitis: A Systematic Review and Meta-analysis.
    Clin Gastroenterol Hepatol. 2019;17:411-418.
    PubMed     Abstract available


  253. SIMSEK M, Meijer B, Ramsoekh D, Bouma G, et al
    Clinical Course of Nodular Regenerative Hyperplasia in Thiopurine Treated Inflammatory Bowel Disease Patients.
    Clin Gastroenterol Hepatol. 2019;17:568-570.
    PubMed     Abstract available


  254. CHRISTENSEN B, Gibson PR, Micic D, Colman RJ, et al
    Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2019;17:486-493.
    PubMed     Abstract available


    January 2019
  255. HANAUER S, Panaccione R, Danese S, Cheifetz A, et al
    Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019;17:139-147.
    PubMed     Abstract available


  256. FEAGAN BG, Lasch K, Lissoos T, Cao C, et al
    Rapid Response to Vedolizumab Therapy in Biologic-Naive Patients With Inflammatory Bowel Diseases.
    Clin Gastroenterol Hepatol. 2019;17:130-138.
    PubMed     Abstract available


  257. KHALILI H, Hakansson N, Chan SS, Ludvigsson JF, et al
    No Association Between Consumption of Sweetened Beverages and Risk of Later-Onset Crohn's Disease or Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019;17:123-129.
    PubMed     Abstract available


  258. KRUIS W, Neshta V, Pesegova M, Alekseeva O, et al
    Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative Proctitis.
    Clin Gastroenterol Hepatol. 2019;17:98-106.
    PubMed     Abstract available


  259. ANANTHAKRISHNAN AN, Martin C, Kane S, Sandler RS, et al
    Paternal Disease Activity Is Associated With Difficulty in Conception Among Men With Inflammatory Bowel Diseases.
    Clin Gastroenterol Hepatol. 2019;17:203-204.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: